Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fingolimod for COVID-19 Pneumonia
NCT04280588Phase 2Withdrawn
- Sponsor
- The First Hospital of Fujian Medical University
- Start
- Feb 2020
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fingolimod in coronavirus disease 2019 (COVID-19), sponsored by The First Hospital of Fujian Medical University. Planned start Feb 2020; status: withdrawn.
02
Drugs
fingolimod
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04280588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04280588.